Axonics vs. Medtronic - The Battle Is On for OAB Neuromodulation

Posted by Clark Love on Oct 14, 2022 10:52:57 AM

There are many ways to treat and manage conditions like overactive bladder (OAB). But could a market brouhaha over neuromodulation IP impact how practitioners leverage established treatments?


The two main players in the field, Medtronic and Axonics, have been butting heads for a while. Both are determined to dominate the OAB treatment market segment that could always use more attention, and the winner will likely be the company that is most innovative over the longer-term. The battle is truly one of “David versus Goliath”.  Here's what the battle for the OAB neuromodulation crown might mean for urology and urogynecology practices.

Read More

Topics: OAB Neuromodulation

We hope our blog is helpful.  Please leave us your thoughts and feel free to share any posts of interest to you on your social media accounts using the social media links at the top.

Subscribe to Email Updates

Recent Posts

Posts by Topic

see all